Afrigen
Low cost and open source: vaccines in developing countries
In South Africa, a scientific knowledge transfer hub is working to create a Covid-19 vaccine based on the publicly available sequence of Moderna's mRNA vaccine, without Moderna's involvement but with its approval. In India, scientists are also testing a vaccine to fight SARS-CoV-2. These seem to be big steps for developing countries in order to ...
A scientist’s opinion: interview with Petro Terblanche on the first African vaccine hub
Petro Terblanche is Health Science Professor at North-West University and is Managing Director at Afrigen Biologics in South Africa. Next to developing an open source vaccine, Afrigen hosts a global vaccine hub to build capacity and capabilities in low- and middle-income countries to design, develop and produce messenger RNA (mRNA) vaccines. Professor Terblanche, as managing ...